← Journal
Day 70 Bioelectricity · Aging · The Smolder Masterpiece edition · 14 min read

Inflammaging: The Slow Fire of Getting Older

Yesterday we found that inflammation is a fire — protective when it flares and resolves, corrosive when it smolders. Today we follow the smolder across a lifetime. Because as we age, the body's fire never fully goes out. Beneath the surface, with no wound to heal and no germ to fight, a low, sterile inflammation rises quietly across the decades — the inflammatory tone of a fifty-year-old, on average, running higher than that of a twenty-year-old, even in the absence of any disease. Scientists have a name for it: inflammaging. It is real, it is increasingly tied to the diseases of later life, and precisely because it is real, the gadgets and supplements promising to "reverse aging" by "eliminating inflammation" are selling a fire extinguisher for a fire you cannot — and must not — simply put out.

Inflammaging — a low, sterile ember-glow smoldering through an aging network of light
Bioelectricity · Aging · The Smolder

A word for a slow fire

The term was coined in 2000 by the Italian immunologist Claudio Franceschi and colleagues, who spelled it "inflamm-aging" and framed it in evolutionary terms.[1] Their insight was that the very inflammatory machinery that keeps us alive when we are young — fighting infections, healing wounds — extracts a rising cost as the decades accumulate, tilting the body toward a chronic, low-grade, sterile pro-inflammatory state. "Sterile" is the crucial word: there is no pathogen behind it, no injury. It is the fire without the spark. In the years since, Franceschi and Judith Campisi crystallized the stakes.

Human aging is characterized by a chronic, low-grade inflammation, and this phenomenon has been termed "inflammaging." … most if not all age-related diseases share an inflammatory pathogenesis. — Franceschi & Campisi, 2014

A word on the numbers, because honesty demands it: these are trends across populations, not a dial on any individual. On average, across large cohorts, markers such as IL-6 and C-reactive protein rise with age — a commonly cited approximation puts the low-grade elevation on the order of two- to fourfold over young-adult baseline — but individuals of the same age vary enormously, and some older adults keep a strikingly low inflammatory tone.[5] There is no single number that says "you have inflammaging." The finding is a direction, not a verdict.

~2–4×the low-grade rise (approx., on average)
2000Franceschi coins "inflammaging"
12hallmarks of aging (inflammation added 2023)

Where the smoke comes from

What keeps a fire burning with no fuel to light it? Several sources, interlocking, none sufficient alone. The most important is cellular senescence. As tissues age, they accumulate cells that have permanently stopped dividing but stubbornly refuse to die. Many of these senescent cells do not go quiet; instead they adopt what Judith Campisi's group named the senescence-associated secretory phenotype, or SASP — they secrete a steady cocktail of inflammatory cytokines, proteases, and growth factors into the tissue around them.[3] Each senescent cell becomes a tiny, stationary inflammation factory, and they pile up with the years. It is a haunting image: cells that will neither divide nor die, sitting in your tissues and quietly stoking the fire.

Senescence is not the only source. Aging tissues accumulate molecular debris and danger signals (DAMPs) faster than they can be cleared — a process wryly nicknamed "garb-aging," inflammation driven by cellular garbage. The immune system itself remodels with age (immunosenescence), losing some of its precision while settling into a chronically primed inflammatory tone. And the aging gut becomes leakier, its microbiome shifts, and microbial products seep out to stoke the systemic smolder. Layer on the chronic-stress and allostatic load of a long life, and the failed resolution we met yesterday, and you have a fire fed from many directions at once.

A hallmark of aging

How central is this? Central enough that the field has formally enshrined it. In 2013, a landmark paper by López-Otín, Blasco, Partridge, Serrano, and Kroemer catalogued the Hallmarks of Aging — nine core processes, among them cellular senescence, that together drive the aging of an organism.[4] A decade later, their 2023 update, subtitled "An expanding universe," widened the list to twelve — and explicitly added chronic inflammation as a hallmark in its own right, alongside disabled cellular recycling and gut dysbiosis. In other words, by 2023 the smoldering fire of inflammaging is no longer a side effect of aging in the mainstream account. It is counted among aging's defining features. And that recognition matters, because it tracks the associations: in large cohorts, a higher inflammatory tone predicts worse physical and cognitive performance and higher mortality, and chronic inflammation shares mechanisms with atherosclerosis, type 2 diabetes, neurodegeneration, frailty, and the muscle loss of sarcopenia.

  1. Step 1 · AgingDecades of accumulated wearTime brings accumulating molecular and cellular damage across the body's tissues.
  2. Step 2 · Senescent cells + damage"Garb-aging"Non-dividing senescent cells build up; debris and danger signals (DAMPs) accumulate faster than they can be cleared.
  3. Step 3 · SASP + failed resolutionThe fire is fed and not put outSenescent cells secrete inflammatory cytokines (SASP); the normal active resolution of inflammation increasingly falls short.[3]
  4. Step 4 · Chronic low-grade inflammationInflammagingA persistent, sterile smolder — no pathogen — running on the order of a few-fold above young-adult baseline, on average.[1]
  5. Step 5 · Associated with age-related diseasePartly modifiableLinked (largely by association) to cardiovascular disease, diabetes, neurodegeneration, and frailty; behavior can shift the tone; senolytics are experimental.

Where the honesty lives

Inflammaging is sobering biology, and its very seriousness is what the longevity-marketing industry has learned to exploit. The overclaims arrive in a familiar shape: supplements, "anti-inflammatory" devices, "frequencies," and wearables that promise to reduce your inflammation and thereby slow or reverse aging. Three honest points dismantle this. First, the causal picture is mostly association: a high inflammatory tone reliably predicts worse outcomes, but "predicts" is not "causes," and the precise causal weight of inflammaging in any specific disease is still being worked out. Second — and this is where the real science is genuinely thrilling — the most promising direct intervention, senolytics (drugs that selectively clear senescent cells), remains a research frontier: striking in mice, tested in only small, early human trials (one of which required a corrigendum revising some of its conclusions), and emphatically not an available, proven anti-aging therapy.[6] Anyone selling "senescence-clearing" benefits from a gadget is far ahead of the evidence.

And third, the deepest point, the same one that closed yesterday's essay: inflammation is essential. You cannot abolish it, and you would not want to — a body that cannot inflame cannot heal or defend itself. So a device that claims to "eliminate inflammation" is not offering health; it is describing something that, taken literally, would be dangerous. What actually is associated with a lower inflammatory tone and better aging is unglamorous and unpurchasable: regular physical activity, not smoking, adequate sleep, sensible dietary patterns, and the treatment of real, diagnosed disease. Those are not products. They are a way of living. The honest, and frankly liberating, conclusion is that the strongest levers on the slow fire of aging are already in your hands — and none of them has a "buy now" button.

The careful 2026 reading

Established: inflammatory markers (IL-6, CRP, TNF-α) rise on average with age across large cohorts, and chronic low-grade 'inflammaging' (coined by Franceschi et al., 2000) is associated with age-related disease, frailty, and mortality (Franceschi & Campisi 2014; large cohorts). Drivers include cellular SENESCENCE and the SASP (senescent cells secreting inflammatory factors; Campisi/Coppé et al. 2008), accumulating damage/DAMPs ('garb-aging'), immunosenescence, and gut/microbiome shifts. Chronic inflammation was formally added as a hallmark of aging in 2023 (López-Otín et al. 2013 → 2023, twelve hallmarks). Numbers are population trends (~2–4× is an approximation), not individual metrics, and vary enormously between people. Frontier (real, unproven): SENOLYTICS / senotherapeutics to clear senescent cells — striking in mice, only small/early human trials (one with a corrigendum), NOT an established anti-aging therapy; whether lowering inflammaging extends human healthspan is open; most disease links are association, not proven causation. Rejected / overclaimed: anti-aging supplements, 'anti-inflammatory' devices/'frequencies,' and cure-alls claiming to 'reverse aging' or 'eliminate inflammation' — inflammation is essential and cannot/should not be abolished; the evidence-associated levers are behavioral (exercise, not smoking, sleep, diet, treating real disease), not a purchase. Tesla BioLights makes no medical claims.

Quick answers

What is inflammaging?

The chronic, low-grade, sterile (no pathogen) inflammation that tends to rise with age — coined by Franceschi and colleagues in 2000. On average, markers like IL-6 and CRP climb with the decades even without disease, and this smolder is increasingly associated with age-related illness. It's essentially failed resolution of inflammation across a lifespan.

What drives it?

Cellular senescence and the SASP (senescent cells that won't divide or die, secreting inflammatory cytokines; Campisi), accumulating debris/DAMPs ("garb-aging"), immunosenescence, and gut/microbiome changes — plus chronic stress and failed resolution. None acts alone.

Is it a hallmark of aging?

Yes, since 2023. The Hallmarks of Aging framework (López-Otín et al.) listed nine in 2013; the 2023 update expanded to twelve and explicitly added chronic inflammation as a hallmark in its own right.

Can senolytics or supplements reverse aging by lowering inflammation?

Not as a proven therapy. Senolytics are a real frontier — striking in mice, only early/small human trials (one with a corrigendum), not established. Anti-aging supplements and "anti-inflammatory" devices claiming to reverse aging are a non-sequitur. The associated levers are behavioral, and inflammation can't be abolished.

Does inflammaging cause age-related disease?

Mostly it's associated with it, not proven to cause it. Higher markers predict worse outcomes and share mechanisms with several diseases, but most links are correlation with causal evidence emerging only in specific niches. That's exactly why sweeping "lower inflammation to prevent aging" product claims overreach.

Does Tesla BioLights make medical claims about this?

No. Zero medical claims. Inflammaging is real and largely a matter of association — precisely why "reverse aging by lowering inflammation with a device" doesn't follow. Senolytics are unproven; the real levers are behavioral. Nothing here validates any product.

Bioelectric Mechanisms · The clock · The alarm · The toll · The fire · The smolder · Biofield Hub →

Tomorrow on the Journal

Day 71 — Autophagy: How the Cell Cleans House. If accumulating cellular garbage feeds the slow fire, what clears it? The cell's own recycling system — the self-eating process that won Yoshinori Ohsumi the 2016 Nobel Prize, is itself a hallmark of aging, and is the subject of some of the most overheated "fasting hack" claims on the internet. The honest mechanism, and where it ends.

References

  1. Franceschi C, Bonafè M, Valensin S, et al. Inflamm-aging: An Evolutionary Perspective on Immunosenescence. Ann N Y Acad Sci. 2000;908:244–254. DOI 10.1111/j.1749-6632.2000.tb06651.x. PMID 10911963. The coinage of "inflammaging."
  2. Franceschi C, Campisi J. Chronic Inflammation (Inflammaging) and Its Potential Contribution to Age-Associated Diseases. J Gerontol A Biol Sci Med Sci. 2014;69(Suppl 1):S4–S9. DOI 10.1093/gerona/glu057. PMID 24833586. The disease-association framing (source of the pull-quote).
  3. Coppé J-P, Patil CK, Rodier F, et al. (Campisi J). Senescence-Associated Secretory Phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6(12):e301. DOI 10.1371/journal.pbio.0060301. PMID 19053174. The characterization of the SASP.
  4. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The Hallmarks of Aging. Cell. 2013;153(6):1194–1217. DOI 10.1016/j.cell.2013.05.039. PMID 23746838. And the 2023 update, "Hallmarks of aging: An expanding universe," Cell. 2023;186(2):243–278. DOI 10.1016/j.cell.2022.11.001. PMID 36599349 (chronic inflammation added as a hallmark).
  5. Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15(9):505–522. DOI 10.1038/s41569-018-0064-2. Markers, mechanisms, and disease links. Cohort context: Puzianowska-Kuźnicka M, et al., Immun Ageing. 2016;13:21 (DOI 10.1186/s12979-016-0076-x); Woods JA, et al., Aging Dis. 2012;3(1):130–140 (PMID 22500274, the ~2–4× approximation). Background: StatPearls, Chronic Inflammation, NBK493173.
  6. Hickson LJ, et al. (Tchkonia T, Kirkland JL). Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019;47:446–456. DOI 10.1016/j.ebiom.2019.08.069. PMID 31542391 (with corrigendum, PMID 31982828). Senolytics as an early, unproven frontier.
History of science · Documented · No medical claims · The smolder

The strongest levers on the slow fire are already in your hands.

Inflammaging is real, sobering, and largely a matter of association — which is exactly why "reverse aging by lowering inflammation" gadgets and supplements don't follow. Senolytics are an unproven frontier; the evidence-associated levers are behavioral, not for sale. The honest ledger keeps the science, the frontier, and the overclaim apart. Tesla BioLights makes no medical claims and is validated by none of this.

Schedule a Session The Lineage
The Journal

One peer-reviewed essay per day

Franceschi, Campisi, López-Otín, Kroemer, Kirkland. Every name is documented. Every claim is cited — and every boundary is drawn.